Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis
Authors:
- Tilman ZieglerTZTilman Ziegler
- Jan HorstkotteJHJan Horstkotte
- Claudia SchwabCSClaudia Schwab
- Vanessa PfetschVPVanessa Pfetsch
- Karolina WeinmannKWKarolina Weinmann
- Steffen DietzelSDSteffen Dietzel
- Ina RohwedderIRIna Rohwedder
- Rabea HinkelRHRabea Hinkel
- Lisa GrossLGLisa Gross
- Seungmin LeeSLSeungmin Lee
- Junhao HuJHJunhao Hu
- Oliver SoehnleinOSOliver Soehnlein
Open Access
- 1 July 2013
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 123 (8) , 3436-3445
Abstract
Septic shock is characterized by increased vascular permeability and hypotension despite increased cardiac output. Numerous vasoactive cytokines are upregulated during sepsis, including angiopoietin 2 (ANG2), which increases vascular permeability. Here we report that mice engineered to inducibly overexpress ANG2 in the endothelium developed sepsis-like hemodynamic alterations, including systemic hypotension, increased cardiac output, and dilatory cardiomyopathy. Conversely, mice with cardiomyocyte-restricted ANG2 overexpression failed to develop hemodynamic alterations. Interestingly, the hemodynamic alterations associated with endothelial-specific overexpression of ANG2 and the loss of capillary-associated pericytes were reversed by intravenous injections of adeno-associated viruses (AAVs) transducing cDNA for angiopoietin 1, a TIE2 ligand that antagonizes ANG2, or AAVs encoding PDGFB, a chemoattractant for pericytes. To confirm the role of ANG2 in sepsis, we i.p. injected LPS into C57BL/6J mice, which rapidly developed hypotension, acute pericyte loss, and increased vascular permeability. Importantly, ANG2 antibody treatment attenuated LPS-induced hemodynamic alterations and reduced the mortality rate at 36 hours from 95% to 61%. These data indicate that ANG2-mediated microvascular disintegration contributes to septic shock and that inhibition of the ANG2/TIE2 interaction during sepsis is a potential therapeutic target.Keywords
This publication has 45 references indexed in Scilit:
- Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signalingJournal of Clinical Investigation, 2012
- Angiopoietin-1 is essential in mouse vasculature during development and in response to injuryJournal of Clinical Investigation, 2011
- Pericyte Requirement for Anti-Leak Action of Angiopoietin-1 and Vascular Remodeling in Sustained InflammationThe American Journal of Pathology, 2011
- Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in miceJournal of Clinical Investigation, 2010
- Angiopoietin-2 Stimulation of Endothelial Cells Induces αvβ3 Integrin Internalization and DegradationJournal of Biological Chemistry, 2010
- Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropeniaBMC Infectious Diseases, 2010
- Angiopoietin-2 Confers Atheroprotection in apoE −/− Mice by Inhibiting LDL Oxidation via Nitric OxideCirculation Research, 2009
- Time course of angiopoietin-2 release during experimental human endotoxemia and sepsisCritical Care, 2009
- Adeno-Associated Virus (AAV) Serotype 9 Provides Global Cardiac Gene Transfer Superior to AAV1, AAV6, AAV7, and AAV8 in the Mouse and RatHuman Gene Therapy, 2008
- Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in HumansPLOS Medicine, 2006